Clinical Research Directory
Browse clinical research sites, groups, and studies.
Phase 2 Study of KH001 in Long-term Relief From Dentin Hypersensitivity
Sponsor: HysensBio Co., Ltd
Summary
The purpose of this study is to evaluate the efficacy and safety of KH001 in subjects with dentin hypersensitivity.
Official title: A Randomized, Double-blinded, Placebo-controlled, Phase 2 Study to Assess the Efficacy and Safety of Three Topical Applications of KH001 in Providing Long-term Relief From Dentin Hypersensitivity
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2024-10-08
Completion Date
2025-12-22
Last Updated
2026-10-29
Healthy Volunteers
No
Conditions
Interventions
KH001
Application of KH001 over a 1 or 2-week period
Placebo
Applications of water for injection
Locations (2)
ADA Forsyth
Cambridge, Massachusetts, United States
Forsyth Institute
Cambridge, Massachusetts, United States